Princeton Biopharma Capital Partners, LLC
Michael has over 20 years of experience in the healthcare industry with a successful track record of forming and growing new enterprises. He founded Princeton Biopharma Capital Partners, LLC is a private equity firm. Prior to Princeton Biopharma, he was the founder and CEO of Aton Pharma, Inc., acquired by Valeant Pharmaceuticals for $330 million. He was a recipient of the Ernst & Young Entrepreneur of the Year Award in 2009.
Michael also serves on the boards of Covis Pharma S.à.r.l, Curaseal, and Princeton Biopharma. He holds both a Bachelor’s and Master’s of Science from the University of Pittsburgh and a MBA from The Wharton School.